Riskpilot← Back to searchSign inGet full accessOmmodoc AB
ABActiveOrg 5593746844Vindragaregatan 8 BMedical specialists activities · NACE 8622Est. 20220 employees
Revenue 2025
SEK 19K
-58% vs 2024
EBITDA margin
-50.4%
-211% vs 2024
Equity ratio
100.0%
Financial strength
Net profit 2025
SEK -10K
-211% vs 2024
| Revenue | SEK 19K | -58% |
| EBITDA | SEK -10K | -211% |
| Net profit | SEK -10K | -211% |
| Total assets | SEK 29K | -25% |
| Equity | SEK 29K | -25% |
| Employees | 0 | — |
Legal name
Ommodoc AB
Org number
5593746844
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
6 april 2022
Share capital
SEK 43 250
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas ensam av Svensson, Nuha
Company purpose
Bolaget skall förmedla hälsa- och sjukvårdstjänster online och därmed förenlig verksamhet.
Address
Vindragaregatan 8 B
Email
office@nsproconsulting.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | 0 | 36 | 46 | 19 |
| Staff expenses | — | — | — | — |
| EBITDA | −14 | 1 | 9 | −10 |
| Depreciation & amort. | — | — | — | — |
| EBIT | −14 | 1 | 9 | −10 |
| Net financials | — | — | — | 0 |
| Profit before tax | −14 | 1 | 9 | −10 |
| Tax | — | — | — | — |
| Net profit | −14 | 1 | 9 | −10 |
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 17 | 32 | 39 | 29 |
| Equity | 17 | 30 | 39 | 29 |
| Long-term debt | — | — | — | — |
| Short-term debt | — | 2 | 0 | 0 |
| Total debt | — | 2 | — | — |
EBITDA margin
-50.4%
This company
15.8%
Market median
-419% vs market
20222025
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20222025
Return on equity
-33.1%
This company
18.4%
Market median
-280% vs market
20222025
Net profit margin
-50.3%
This company
8.1%
Market median
-721% vs market
20222025
Asset turnover
0.66×
This company
1.12×
Market median
-41% vs market
20222025
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20222025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-04-06 – 2022-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
OA Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2026 | — | — | |
| Chairman | 2022 | — | — | |
| Deputy Board Member | 2026 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2022 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Ommodoc AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Olof Axel Thoreson | Chief Executive Officer | 0 companies |
| Nuha Svensson | Board of Directors | 0 companies |
| Carl Oscar Zaar | Chairman | 0 companies |
| Jim Henry Törnfeldt | Deputy Board Member | 0 companies |
| Johan Viktor Mattias Brycke | Board of Directors | 0 companies |
| Carl Martin Sandberg Wideqvist | Board of Directors | 0 companies |